Skip to content

Clinical trials

Completed Phase 3 Hematologic Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Neoplasms Phase: Phase 3 Status: Completed Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20071
20083
20093
20101
20112
20121
20132
20141
20152
20164
20171
20191
20203
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed29

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center4
M.D. Anderson Cancer Center3
Gamida Cell ltd2
Novartis Pharmaceuticals2
Ottawa Hospital Research Institute2
Academic and Community Cancer Research United1
Alliance for Clinical Trials in Oncology1
Amgen1
Augusta University1
Children's Oncology Group1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Neoplasms29
Invasive Fungal Infections3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive3
Lymphoma, Large B-Cell, Diffuse3
Multiple Myeloma3
Myelodysplastic Syndromes3
Bone Marrow Diseases2
Hodgkin Disease2
Leukemia2
Leukemia, Lymphocytic, Chronic, B-Cell2

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.